表紙
市場調查報告書

全球病毒載體及質體DNA製造市場:產業分析,規模,佔有率,成長,趨勢,預測

Global Viral Vector & Plasmid DNA Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025

出版商 Value Market Research 商品編碼 838393
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
全球病毒載體及質體DNA製造市場:產業分析,規模,佔有率,成長,趨勢,預測 Global Viral Vector & Plasmid DNA Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025
出版日期: 2019年03月01日內容資訊: 英文
簡介

本報告提供全球病毒載體及質體DNA製造市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介相關資訊。

第1章 簡介

第2章 摘要整理

第3章 市場分析

  • 簡介
  • 價值鏈分析
  • 促進要素
  • 阻礙要素
  • 機會
  • 波特五力分析

第4章 各產品市場分析

  • 腺病毒
  • 慢病毒
  • 腺相關病毒
  • 質體DNA
  • 其他

第5章 各用途市場分析

  • 基因治療,癌症治療
  • 病毒疫苗
  • 蛋白質表現研究
  • 其他

第6章 各終端用戶市場分析

  • 醫院
  • 生物醫藥品企業
  • 研究機關
  • 其他

第7章 各地區市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭環境

  • 市場上競爭
  • 聯盟/聯合/協定
  • 合併·收購
  • 新產品上市
  • 其他開發

第9章 企業簡介

  • Cobra Biologics
  • FinVector Vision Therapies
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • General Electric Company (GE Healthcare)
  • Kaneka Corporation (Eurogentec)
  • Lonza
  • Novasep
  • Sigma-Aldrich Co. LLC
  • SIRION Biotech GmbH
  • VGXI, Inc.
  • VIROVEK
目錄

The report on Global Viral Vector & Plasmid DNA Manufacturing Market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2025. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

  • Drivers
    • Growing advancement in gene therapy
    • Rising demand for high doses biopharmaceutical drugs
  • Restraints
    • High cost of the gene therapies

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Till: 2025

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on product type, application and end-user. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Cobra Biologics, FinVector Vision Therapies, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., General Electric Company (GE Healthcare), Kaneka Corporation (Eurogentec), Lonza, Novasep, Sigma-Aldrich Co. LLC, SIRION Biotech GmbH, VGXI, Inc.,and VIROVEK. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Product Type:

  • Adenovirus
  • Lentivirus
  • Adeno-Associated Virus (AAV)
  • Plasmid DNA
  • Others

By Application:

  • Gene and Cancer Therapies
  • Viral Vaccines
  • Protein Expression Studies
  • Others

By End-User:

  • Hospitals
  • Biopharmaceutical Companies
  • Research Institutes
  • Others

By Geography:

  • North America (NA) - US, Canada & Rest of North America
  • Europe (EU) - UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) - China, Japan, India & Rest of APAC
  • Latin America (LA) - Brazil & Rest of Latin America
  • Middle East & Africa (MEA) - Middle East and Africa

Table of Contents

1. INTRODUCTION

  • Report Description
  • Research Scope
  • Research Methodology

2. EXECUTIVE SUMMARY

  • Market Highlight
  • Global Viral Vector & Plasmid DNA Manufacturing Market: Snapshot

3. MARKET ANALYSIS

  • Introduction
  • Value Chain Analysis
  • Drivers
  • Restraints
  • Opportunities
  • Porter's Five Forces Analysis

4. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY PRODUCT

  • Market In Adenovirus
  • Market In Lentivirus
  • Market In Adeno-Associated Virus (AAV)
  • Market In Plasmid DNA
  • Market In Others

5. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY APPLICATION

  • Market In Gene And Cancer Therapies
  • Market In Viral Vaccines
  • Market In Protein Expression Studies
  • Market In Others

6. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY END-USER

  • Market In Hospitals
  • Market In Biopharmaceutical Companies
  • Market In Research Institutes
  • Market In Others

7. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

  • North America (NA)
  • North America Market Estimates
  • North America Market Estimates By Country
  • United States (U.S.)
  • Canada
  • Rest Of North America
  • Europe (EU)
  • Europe Market Estimates
  • Europe Market Estimates By Country
  • United Kingdom (UK)
  • Germany
  • France
  • Rest Of Europe
  • Asia Pacific (APAC)
  • Asia Pacific Market Estimates
  • Asia Pacific Market Estimates By Country
  • China
  • Japan
  • India
  • Rest Of Asia Pacific
  • Latin America (LA)
  • Latin America Market Estimates
  • Latin America Market Estimates By Country
  • Brazil
  • Rest Of Latin America
  • Middle East And Africa (MEA)
  • Middle East And Africa Market Estimates
  • Middle East And Africa Market Estimates By Country
  • Middle East
  • Africa

8. COMPETITIVE LANDSCAPE OF THE VIRAL VECTOR & PLASMID DNA MANUFACTURING COMPANIES

  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments

9. COMPANY PROFILES OF THE VIRAL VECTOR & PLASMID DNA MANUFACTURING INDUSTRY (Company Overview, Financial, Major Products & Recent Development)

  • Cobra Biologics
  • FinVector Vision Therapies
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • General Electric Company (GE Healthcare)
  • Kaneka Corporation (Eurogentec)
  • Lonza
  • Novasep
  • Sigma-Aldrich Co. LLC
  • SIRION Biotech GmbH
  • VGXI, Inc.
  • VIROVEK
  • Tentative TOC